longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

YUYUE MEDICAL

002223

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 22.65, above the reasonable range, cheaper than 10.65% of the time in the past 5 years, and the industry ranks 10/65, the industry Median 26.75.

22.65xP/E
¥25.35Stock price
¥1.12Earnings per share
22.65xP/E
Stock price¥25.35Earnings per share¥1.12

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
19.86x
Typical range
16.53x–21.44x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 26.75x
013263952

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 26.75x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
300760SZMindray
25.08x1.70%¥197.20B
002223SZYUYUE MEDICAL
22.65x0.70%¥25.41B
300003SZLepu Medical
26.75x16.83%¥20.61B
002901SZDouble Medical
22.61x13.61%¥16.02B
603014SHWeigao Blood Purification
26.15x2.19%¥12.86B
300529SZJAFRON
22.77x18.12%¥11.96B
600587SHSHINVA
17.45x--¥7.43B
300206SZEdan
18.36x--¥6.48B
301367SZBMC
24.81x27.60%¥5.48B
688236SHChunli Medical
18.45x0.00%¥5.13B
688581SHAGS
20.92x79.57%¥4.47B
300326SZKinetic Medical
19.63x--¥4.42B
688410SHSWS Medical
22.39x45.87%¥4.15B
688580SHVISHEE
22.97x20.83%¥3.88B
301033SZMedprin
27.93x--¥3.42B
688358SHCHISON MEDICAL
25.91x17.31%¥3.00B
688314SHKontour Medical
28.67x--¥2.44B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.